Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,350 | 1 | 70.6% |
| Food and Beverage | $686.50 | 9 | 20.6% |
| Travel and Lodging | $291.96 | 1 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $2,779 | 6 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $250.00 | 3 | $0 (2018) |
| Boston Scientific Corporation | $168.74 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $131.01 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131.01 | 1 | Mallinckrodt Hospital Products Inc. ($131.01) |
| 2023 | $168.74 | 1 | Boston Scientific Corporation ($168.74) |
| 2018 | $2,834 | 6 | Gilead Sciences, Inc. ($2,767) |
| 2017 | $194.89 | 3 | Novartis Pharmaceuticals Corporation ($183.14) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $131.01 | General |
| Category: CRITICAL CARE | ||||||
| 09/25/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $168.74 | General |
| Category: General - Therapies_ENDO | ||||||
| 10/10/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $66.86 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Consulting Fee | Cash or cash equivalent | $2,350.00 | General |
| Category: HBV | ||||||
| 04/28/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: HBV | ||||||
| 04/28/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: HBV | ||||||
| 04/28/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: HBV | ||||||
| 04/27/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $291.96 | General |
| Category: HBV | ||||||
| 11/13/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $73.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $109.33 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $11.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 208 | 369 | $77,088 | $24,052 |
| 2022 | 4 | 177 | 285 | $56,667 | $17,878 |
| 2021 | 8 | 253 | 454 | $95,585 | $33,824 |
| 2020 | 7 | 236 | 377 | $73,021 | $22,836 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 155 | 222 | $47,952 | $14,014 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 117 | $17,784 | $6,719 | 37.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 18 | $7,596 | $2,330 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,756 | $988.40 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 130 | 193 | $41,688 | $12,929 | 31.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 61 | $9,272 | $3,267 | 35.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 13 | 13 | $2,899 | $1,022 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 18 | $2,808 | $659.28 | 23.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 105 | 155 | $33,480 | $11,570 | 34.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 126 | $19,152 | $6,857 | 35.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 80 | $17,360 | $6,260 | 36.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 17 | $7,174 | $2,577 | 35.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 16 | 18 | $5,274 | $2,012 | 38.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 19 | $5,453 | $1,951 | 35.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 22 | 24 | $5,352 | $1,928 | 36.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 15 | $2,340 | $668.33 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 88 | 120 | $25,920 | $6,560 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 115 | $17,480 | $6,360 | 36.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 41 | $8,897 | $3,255 | 36.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 23 | 24 | $5,352 | $1,966 | 36.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 18 | 18 | $5,166 | $1,893 | 36.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 21 | 22 | $4,014 | $1,158 | 28.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 19 | $4,104 | $1,004 | 24.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 17 | 18 | $2,088 | $639.06 | 30.6% |
About Dr. Marco Lacerda, M.D
Dr. Marco Lacerda, M.D is a Gastroenterology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386774172.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marco Lacerda, M.D has received a total of $3,328 in payments from pharmaceutical and medical device companies, with $131.01 received in 2024. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,350).
As a Medicare-enrolled provider, Lacerda has provided services to 874 Medicare beneficiaries, totaling 1,485 services with total Medicare billing of $98,590. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Indianapolis, IN
- Active Since 03/07/2007
- Last Updated 03/14/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1386774172
Products in Payments
- Vemlidy (Drug) $2,767
- ZORTRESS (Drug) $250.00
- TERLIVAZ (Drug) $131.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Indianapolis
Douglas Rex, M.d, M.D
Gastroenterology — Payments: $785,487
Ajay Jain, Md, MD
Gastroenterology — Payments: $435,795
Dr. David Pound, M.d, M.D
Gastroenterology — Payments: $207,527
Raj Vuppalanchi, M.d, M.D
Gastroenterology — Payments: $183,853
Thomas Imperiale, M.d, M.D
Gastroenterology — Payments: $154,570
Glen Lehman, M.d, M.D
Gastroenterology — Payments: $98,291